SAN FRANCISCO — Use of a functional scoring system dramatically reduced morphine treatment and length of stay among infants with neonatal abstinence syndrome (NAS) compared with the widely used ...

Although morphine is the drug almost exclusively used for neonatal abstinence syndrome (NAS), emerging data suggest that buprenorphine may be an acceptable and perhaps safer alternative. The two ...

Although clinicians have traditionally used the Finnegan Neonatal Abstinence Scoring Tool to assess the severity of neonatal opioid withdrawal, a newer function-based approach — the Eat, Sleep, ...

A quality improvement (QI) initiative that focused on using non-pharmacologic approaches to care for infants with neonatal abstinence syndrome (NAS) yielded positive short-term outcomes for both the ...

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics. And from ...